• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区和个体健康社会决定因素与心房颤动患者药物治疗依从性的关系:一项回顾性队列研究。

Associations of Community and Individual Social Determinants of Health With Medication Adherence in Patients With Atrial Fibrillation: A Retrospective Cohort Study.

机构信息

Socially Determined Inc. Washington DC USA.

Pfizer Inc, US Medical Affairs New York NY USA.

出版信息

J Am Heart Assoc. 2023 Apr 18;12(8):e026745. doi: 10.1161/JAHA.122.026745. Epub 2023 Apr 7.

DOI:10.1161/JAHA.122.026745
PMID:37026552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10227243/
Abstract

Background Despite guideline-recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF in the United States ranges from 47% to 82%. To characterize potential causes of nonadherence, we analyzed associations between community and individual social risk factors and OAC adherence for stroke prevention in AF. Methods and Results A retrospective cohort analysis of patients with AF was conducted using the IQVIA PharMetrics Plus claims data from January 2016 to June 2020, and 3-digit ZIP code-level social risk scores were calculated using American Community Survey and commercial data. Logistic regression models evaluated associations between community social determinants of health, community social risk scores for 5 domains (economic climate, food landscape, housing environment, transportation network, and health literacy), patient characteristics and comorbidities, and 2 adherence outcomes: persistence on OAC for 180 days and proportion of days covered ≥0.80 at 360 days. Of 28 779 patients with AF included in the study, 70.8% of patients were male, 94.6% were commercially insured, and the average patient age was 59.2 years. Multivariable regression found that greater health literacy risk was negatively associated with 180-day persistence (odds ratio [OR]=0.80 [95% CI, 0.76-0.83]) and 360-day proportion of days covered (OR, 0.81 [95% CI, 0.76-0.87]). Patient age and higher AF stroke risk score and AF bleeding risk scores were positively associated with both 180-day persistence and 360-day proportion of days covered. Conclusions Social risk domains, such as health literacy, may affect OAC adherence among patients with AF. Future studies should explore associations between social risk factors and nonadherence with greater geographic granularity.

摘要

背景

尽管在心房颤动(AF)中预防中风推荐使用口服抗凝药物(OAC),但美国 AF 患者的 OAC 用药依从性在 47%至 82%之间。为了描述非依从性的潜在原因,我们分析了社区和个体社会风险因素与 AF 中风预防中的 OAC 依从性之间的关联。

方法和结果

使用 IQVIA PharMetrics Plus 从 2016 年 1 月至 2020 年 6 月的索赔数据,对 AF 患者进行了回顾性队列分析,并使用美国社区调查和商业数据计算了 5 个领域(经济气候、食品景观、住房环境、交通网络和健康素养)的社区社会风险评分的 3 位邮政编码级别的社会风险评分。Logistic 回归模型评估了社区健康决定因素、5 个社区社会风险评分(经济气候、食品景观、住房环境、交通网络和健康素养)、患者特征和合并症与 2 个依从性结果(OAC 180 天的持续时间和 360 天的覆盖比例≥0.80)之间的关联。在纳入研究的 28779 名 AF 患者中,70.8%为男性,94.6%为商业保险,平均患者年龄为 59.2 岁。多变量回归发现,更高的健康素养风险与 180 天的持续时间(比值比[OR] = 0.80 [95%CI,0.76-0.83])和 360 天的覆盖比例(OR,0.81 [95%CI,0.76-0.87])呈负相关。患者年龄以及更高的 AF 中风风险评分和 AF 出血风险评分与 180 天的持续时间和 360 天的覆盖比例均呈正相关。

结论

健康素养等社会风险领域可能会影响 AF 患者的 OAC 依从性。未来的研究应在更大的地理粒度下探索社会风险因素与不依从性之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/f81ea60fd495/JAH3-12-e026745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/68314c8a6955/JAH3-12-e026745-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/9b02af889a05/JAH3-12-e026745-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/f81ea60fd495/JAH3-12-e026745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/68314c8a6955/JAH3-12-e026745-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/9b02af889a05/JAH3-12-e026745-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c5d/10227243/f81ea60fd495/JAH3-12-e026745-g001.jpg

相似文献

1
Associations of Community and Individual Social Determinants of Health With Medication Adherence in Patients With Atrial Fibrillation: A Retrospective Cohort Study.社区和个体健康社会决定因素与心房颤动患者药物治疗依从性的关系:一项回顾性队列研究。
J Am Heart Assoc. 2023 Apr 18;12(8):e026745. doi: 10.1161/JAHA.122.026745. Epub 2023 Apr 7.
2
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.心房颤动患者对直接口服抗凝剂的真实世界依从性和持续性:一项系统评价和荟萃分析。
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9.
3
Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.在新诊断为心房颤动的 Medicare 受益人群中,口服抗凝药依从性的轨迹。
J Am Heart Assoc. 2019 Jun 18;8(12):e011427. doi: 10.1161/JAHA.118.011427. Epub 2019 Jun 13.
4
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.心房颤动抗凝治疗的风险与获益:来自心房颤动更明智治疗结局登记研究(ORBIT - AF)登记处的见解
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):461-9. doi: 10.1161/CIRCOUTCOMES.113.000127. Epub 2013 Jun 11.
5
Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.口服抗凝药物处方趋势、患者特征、以及房颤患者用药依从性的决定因素。
Pharmacotherapy. 2020 Jan;40(1):40-54. doi: 10.1002/phar.2350. Epub 2019 Dec 17.
6
Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.华法林或新型口服抗凝药治疗新诊断非瓣膜性心房颤动的治疗持续性:一项队列研究。
Thromb Haemost. 2016 Jan;115(1):31-9. doi: 10.1160/TH15-04-0350. Epub 2015 Aug 6.
7
Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.医疗保险受益人群新诊断心房颤动后抗凝治疗的依从性与卒中风险。
Am J Cardiovasc Drugs. 2020 Apr;20(2):199-207. doi: 10.1007/s40256-019-00371-3.
8
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).私营医疗保险患者中房颤患者口服抗凝剂的使用率较低:实施一项随机对照试验的目标人群,以改善房颤患者口服抗凝剂的治疗(IMPACT-AFib)。
Am Heart J. 2020 Nov;229:110-117. doi: 10.1016/j.ahj.2020.07.012. Epub 2020 Jul 24.
9
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS to the CHADS-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.在采用CHADS-VASc评分替代CHADS评分进行血栓栓塞风险评估的指南推荐更改后,低至中度卒中风险心房颤动患者口服抗凝药处方的当代趋势:来自国家心血管数据注册中心门诊实践创新与临床卓越心房颤动注册研究的分析
Circ Cardiovasc Qual Outcomes. 2017 May;10(5). doi: 10.1161/CIRCOUTCOMES.116.003476.
10
Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans.比较参加独立处方药计划和医疗保险优势处方药计划的 Medicare 受益人的口服抗凝药物使用情况和依从性。
J Manag Care Spec Pharm. 2022 Feb;28(2):266-274. doi: 10.18553/jmcp.2022.28.2.266.

引用本文的文献

1
Geographic Variation in Persistence of Oral Anticoagulant Treatment Among Patients with Non-Valvular Atrial Fibrillation in the United States.美国非瓣膜性心房颤动患者口服抗凝治疗持续时间的地域差异
J Clin Med. 2025 Sep 5;14(17):6265. doi: 10.3390/jcm14176265.
2
A Platform Designed to Empower Quality Improvement for Patients with Atrial Fibrillation.一个旨在助力心房颤动患者改善治疗质量的平台。
Am J Med Qual. 2025 Apr 17;40(4):156-64. doi: 10.1097/JMQ.0000000000000231.
3
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

本文引用的文献

1
Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.同时参加退伍军人健康管理局和医疗保险的心房颤动患者的种族和民族与抗凝治疗的关联:医疗保险D部分对处方差异的影响。
Circ Cardiovasc Qual Outcomes. 2022 Feb;15(2):e008389. doi: 10.1161/CIRCOUTCOMES.121.008389. Epub 2021 Nov 15.
2
Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence.一种新的患者报告的药物依从性工具的开发:影响药物依从性的因素
Patient Prefer Adherence. 2021 Sep 9;15:1991-2007. doi: 10.2147/PPA.S318030. eCollection 2021.
3
《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
4
Relationship Between Depression and Decreased Activity Level and Cognitive Impairment in Patients with Diabetes Mellitus Type 2 and/or Atrial Fibrillation.2型糖尿病和/或心房颤动患者中抑郁与活动水平降低及认知障碍之间的关系
J Clin Med. 2025 Jan 16;14(2):563. doi: 10.3390/jcm14020563.
5
Impact of Social Determinants of Health on Primary Adherence of Oral Anticoagulants Among Patients with Newly Diagnosed Atrial Fibrillation.健康的社会决定因素对新诊断房颤患者口服抗凝剂初始依从性的影响
Cardiol Ther. 2025 Mar;14(1):53-69. doi: 10.1007/s40119-024-00395-0. Epub 2025 Jan 3.
The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis.
社会健康决定因素对药物依从性的影响:系统评价和荟萃分析。
J Gen Intern Med. 2021 May;36(5):1359-1370. doi: 10.1007/s11606-020-06447-0. Epub 2021 Jan 29.
4
Impact of Multiple Social Determinants of Health on Incident Stroke.多种健康社会决定因素对卒中事件的影响。
Stroke. 2020 Aug;51(8):2445-2453. doi: 10.1161/STROKEAHA.120.028530. Epub 2020 Jul 16.
5
Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.房颤患者口服抗凝剂的依从性:观察性研究的系统评价和荟萃分析。
BMJ Open. 2020 Apr 8;10(4):e034778. doi: 10.1136/bmjopen-2019-034778.
6
Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.种族/民族和性别相关的新发心房颤动直接口服抗凝剂起始差异:医疗保险数据的回顾性研究。
J Natl Med Assoc. 2020 Feb;112(1):103-108. doi: 10.1016/j.jnma.2019.10.003. Epub 2020 Feb 6.
7
Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.在新诊断为心房颤动的 Medicare 受益人群中,口服抗凝药依从性的轨迹。
J Am Heart Assoc. 2019 Jun 18;8(12):e011427. doi: 10.1161/JAHA.118.011427. Epub 2019 Jun 13.
8
Meanings and Misunderstandings: A Social Determinants of Health Lexicon for Health Care Systems.意义与误解:医疗保健系统的健康决定因素词汇
Milbank Q. 2019 Jun;97(2):407-419. doi: 10.1111/1468-0009.12390. Epub 2019 May 8.
9
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
10
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.种族/民族与心房颤动患者口服抗凝药物使用的相关性:来自更好地了解心房颤动治疗的结果登记 II 研究的结果。
JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.